MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517046096 A) filed by Ablynx Nv, Zwijnaarde, Belgium, on May 13, for 'protein-based conjugation carriers.'
Inventor(s) include Boutton, Carlo; Casteels, Peter; Ferrier Berthelot, Alexandra; Ponsaerts, Raf; and Reed, John.
The application for the patent was published on Aug. 1, under issue no. 31/2025.
According to the abstract released by the Intellectual Property India: "The present technology relates to the field of drug delivery and provides molecules comprising or consisting of at least one protein-based carrier building block, wherein the protein-based carrier building block comprises at least one, preferably at least two, attachment point(s) or conjugation site(s). In particular, the technology provides a molecule comprising at least one protein-based building block, wherein the at least one protein-based building block: a) comprises at least one conjugation site or attachment point; b) has a molecular mass of 2.5 to 70 kDa; c) has a globular three-dimensional (3D) structure; d) has a solubility of 10 mg/mL or more, measured in an aqueous solution at room temperature; and does not specifically bind to any human protein or binds one or more human proteins with a KD value greater than 5x10-4 mol/litre."
The patent application was internationally filed on Dec. 22, 2023, under International application No.PCT/EP2023/087731.
Disclaimer: Curated by HT Syndication.
